Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fralick

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 12, 2014
Putting patients first in the age of pharmaMichael Fralick
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 20, 2014
Screening urged for hepatitis C but drug costs are prohibitiveMichael Fralick
JAMA|April 12, 2017
Coagulation Testing in a Bleeding PatientMichael Fralick, Michelle Sholzberg
Journal of Hospital Medicine|July 20, 2023
Methodological progress note: Utilizing inpatient data sources to minimize common biases when emulating target trialsMichael Colacci, Michael Fralick
The New England Journal of Medicine|May 13, 2021
Thyrotoxic Periodic ParalysisMichael Fralick, Shohinee Sarma
NEJM Evidence|February 6, 2024
Pharmacologic Thromboprophylaxis for Patients Admitted to General Medicine - Is It Necessary?Michael Fralick, Michelle Sholzberg
Diabetologia|January 25, 2021
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievementMichael Fralick, Bernard Zinman
Canadian Journal of Diabetes|February 19, 2022
Response: Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-AnalysisMichael Colacci, Michael Fralick
The Canadian Journal of Hospital Pharmacy|May 5, 2020
Have Current Systems of Pharmacovigilance Had Their Day?: THE “PRO” SIDEMichael Colacci, Michael Fralick
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 25, 2017
Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitusNicola Goldberg, Michael Fralick
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 12, 2014
Putting patients first in the age of pharmaMichael Fralick
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 20, 2014
Screening urged for hepatitis C but drug costs are prohibitiveMichael Fralick
JAMA|April 12, 2017
Coagulation Testing in a Bleeding PatientMichael Fralick, Michelle Sholzberg
Journal of Hospital Medicine|July 20, 2023
Methodological progress note: Utilizing inpatient data sources to minimize common biases when emulating target trialsMichael Colacci, Michael Fralick
The New England Journal of Medicine|May 13, 2021
Thyrotoxic Periodic ParalysisMichael Fralick, Shohinee Sarma
NEJM Evidence|February 6, 2024
Pharmacologic Thromboprophylaxis for Patients Admitted to General Medicine - Is It Necessary?Michael Fralick, Michelle Sholzberg
Diabetologia|January 25, 2021
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievementMichael Fralick, Bernard Zinman
Canadian Journal of Diabetes|February 19, 2022
Response: Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-AnalysisMichael Colacci, Michael Fralick
The Canadian Journal of Hospital Pharmacy|May 5, 2020
Have Current Systems of Pharmacovigilance Had Their Day?: THE “PRO” SIDEMichael Colacci, Michael Fralick
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 25, 2017
Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitusNicola Goldberg, Michael Fralick
Pageof 20